The situation of women in Science, Technology, Engineering, and Mathematics (STEM) in Kenya reflects a global trend of underrepresentation, often referred to as a "leaky pipeline," in which female ...
Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to CAR designs tailored for myeloid cells, such as monocytes and macrophages.
Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, announces that it has secured exclusive and non-exclusive licenses to key ...
Prepare for the CBSE Class 10 Science Board Exam 2026 with these top 50 MCQs from previous years' question papers and sample papers. Boost your revision with these must-practice multiple-choice ...
Waters Corporation (NYSE: WAT) ("Waters") today announced it has completed the previously announced combination with the Biosciences & Diagnostic Solutions businesses of Becton, Dickinson and Company ...
MINNEAPOLIS, Feb. 2, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced the launch of Cultrex™ ...
New simulator and computational tools generate realistic ‘virtual tissues’ and map cell-to-cell ‘conversations’ from spatial transcriptomics data, potentially accelerating AI-driven discoveries in ...
Liver fibrosis in the course of metabolic dysfunction-associated steatohepatitis (MASH) could be significantly reduced using CAR T-cells generated in vivo. Scientists at the Icahn School of Medicine ...
Company plans to initiate a Phase 1 clinical study by 1H2026 and share data in 2027 NEOK Bio, Inc., an oncology therapeutics company focused on the development of novel antibody drug conjugates (ADCs) ...
Jan 20 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab and Canada-based privately held Aspect Biosystems said on Tuesday they have struck a partnership to develop cell-based ...
A novel method has enabled scientists to 3D-print structures into live cells, paving the way for a new class of intracellular bioengineering tools and applications. In a first, scientists from the ...
Allogeneic CD19 chimeric antigen receptor-natural killer (CAR-NK) cell therapy showed promise in patients with relapsed or refractory systemic lupus erythematosus (SLE), with sustained efficacy. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results